Quick Answer
Pulmonx Corp reported Net Income Loss of -$54.00 million for the year ending 2025.
- Pulmonx Corp showed an increase of +4.2% in Net Income Loss from 2024 to 2025.
- This data is from Pulmonx Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: -$6.13 million | Q2 2019: -$5.57 million | Q3 2019: -$4.34 million | Q4 2019: -$4.67 million | Q1 2020: -$7.16 million | Q2 2020: -$11.91 million | Q3 2020: -$3.86 million | Q4 2020: -$9.30 million | Q1 2021: -$12.51 million | Q2 2021: -$12.96 million | Q3 2021: -$10.18 million | Q1 2022: -$15.83 million | Q2 2022: -$14.64 million | Q3 2022: -$14.17 million | Q1 2023: -$15.86 million | Q2 2023: -$16.20 million | Q3 2023: -$14.90 million | Q1 2024: -$13.75 million | Q2 2024: -$15.33 million | Q3 2024: -$14.14 million | Q1 2025: -$14.45 million | Q2 2025: -$15.17 million | Q3 2025: -$13.96 million.
- Over the full 8 years of available data (2018 to 2025), Pulmonx Corp's Net Income Loss has declined by 192.2%.
- Historical annual values: Fiscal year 2025: -$54.00 million | Fiscal year 2024: -$56.39 million | Fiscal year 2023: -$60.84 million | Fiscal year 2022: -$58.92 million | Fiscal year 2021: -$48.66 million | Fiscal year 2020: -$32.23 million | Fiscal year 2019: -$20.70 million | Fiscal year 2018: -$18.48 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: